Regulon

Regulon: R-508

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
19-0.91899310Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
81887 ENSG00000001497 LAS1L Q9Y4W2
1994 ENSG00000066044 ELAVL1 Q15717
4775 ENSG00000072736 NFATC3 F8VPH9
23186 ENSG00000089902 RCOR1 Q9UKL0
5422 ENSG00000101868 POLA1 P09884
835 ENSG00000106144 CASP2 P42575
10915 ENSG00000113649 TCERG1 O14776
4691 ENSG00000115053 NCL P19338
23019 ENSG00000125107 CNOT1 H3BPF1
22880 ENSG00000133422 MORC2 Q9Y6X9
8125 ENSG00000140350 ANP32A P39687
22984 ENSG00000148843 PDCD11 Q14690
9794 ENSG00000161021 MAML1 Q92585
79677 ENSG00000163029 SMC6 Q96SB8
171023 ENSG00000171456 ASXL1 Q8IXJ9
2130 ENSG00000182944 EWSR1 Q01844
55660 ENSG00000196504 PRPF40A O75400
11177 ENSG00000198604 BAZ1A Q9NRL2
9656 ENSG00000237095 MDC1 Q14676

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TROXACITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor20
CLOFARABINEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
CYTARABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor41
GEMCITABINE HYDROCHLORIDERRM1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
EMRICASANCASP4Small moleculeINHIBITORCaspase inhibitor20
GEMCITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
ASPACYTARABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor20
FLUDARABINE PHOSPHATEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor41

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-508

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs